From: WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections
Good penetration efficiency | Low penetration efficiency |
---|---|
Piperacillin/tazobactam | Ceftriaxone |
Tigecycline | Cefotaxime |
Amoxicillin/clavulanate | Meropenem |
Ciprofloxacin | Ceftazidime |
Ampicillin/sulbactam | Vancomycin |
Cefepime | Amikacin |
Levofloxacin | Gentamicin |